Login / Signup
Tuğba Yetiş
ORCID
Publication Activity (10 Years)
Years Active: 2024-2024
Publications (10 Years): 2
Top Topics
Chronic Kidney Disease
Patient Reported Outcomes
Ejection Fraction
High Dose
Top Venues
Cancer medicine
</>
This page only lists publications with an associated author ORCID identifier.
Publications
</>
Ant Uzay
,
Yasemin Gündoğdu
,
Barış Koşan
,
Tuğba Yetiş
,
S Sami Kartı
Treosulfan is a safe and effective alternative to busulfan for conditioning in adult allogeneic HSCT patients: Data from a single center.
Cancer medicine
13 (10) (2024)
Ant Uzay
,
Yasemin Gündoğdu
,
Barış Koşan
,
Tuğba Yetiş
,
S Sami Kartı
Treosulfan is a safe and effective alternative to busulfan for conditioning in adult allogeneic HSCT patients: Data from a single center.
Cancer medicine
13 (10) (2024)